HARVARD BUSINESS SCHOOL’s Health Care Initiative launched the Precision Trials Challenge, a competition to bring precision diagnostics and therapies to market more quickly.
“How can we develop business models that support the advancement of precision medicine? How can we get new therapies to market faster and at a lower cost? Our Precision Trials Challenge will help answer these questions by encouraging conversation and helping to put leading-edge ideas into practice,” said professor Richard Hamermesh.
The challenge is accepting applications through March 13. A panel of judges will select one winner and two runners-up to share a $100,000 prize. The winner will be announced in April and have the opportunity to present at the 2016 Personalized Medicine Conference.
The Precision Trials Challenge is funded by the Kraft Endowment for Advancing Precision Medicine, established last fall by a $20 million gift from the Kraft Family Foundation under the leadership of Foundation president Robert K. Kraft.
